Interventions for the management of malignant pleural effusions: a network meta‐analysis
Background Malignant pleural effusion (MPE) is a common problem for people with cancer
as a result of malignant infiltration of the pleura. It is usually associated with considerable …
as a result of malignant infiltration of the pleura. It is usually associated with considerable …
Interventions for the management of malignant pleural effusions: a network meta‐analysis
A Dipper, HE Jones, R Bhatnagar… - Cochrane Database …, 2020 - cochranelibrary.com
Background Malignant pleural effusion (MPE) is a common problem for people with cancer
and usually associated with considerable breathlessness. A number of treatment options are …
and usually associated with considerable breathlessness. A number of treatment options are …
The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusion
M Bradshaw, A Mansfield, T Peikert - Current oncology reports, 2013 - Springer
Malignant pleural effusions (MPEs) are a significant source of cancer-related morbidity. Over
150,000 patients in the United States suffer from breathlessness and diminished quality of …
150,000 patients in the United States suffer from breathlessness and diminished quality of …
[HTML][HTML] Pleural involvement in lung cancer
T Agalioti, AD Giannou… - Journal of thoracic …, 2015 - ncbi.nlm.nih.gov
The pleural space, a sterile secluded environment in the thoracic cavity, represents an
attractive metastatic site for various cancers of lung, breast and gastrointestinal origins …
attractive metastatic site for various cancers of lung, breast and gastrointestinal origins …
A phase II study of bevacizumab with carboplatin-pemetrexed in non-squamous non-small cell lung carcinoma patients with malignant pleural effusions: North East …
K Usui, S Sugawara, M Nishitsuji, Y Fujita, A Inoue… - Lung cancer, 2016 - Elsevier
Background Vascular endothelial growth factor (VEGF) plays a pivotal role in the
pathogenesis of malignant pleural effusion (MPE). Here, a multicenter phase II trial to …
pathogenesis of malignant pleural effusion (MPE). Here, a multicenter phase II trial to …
Phase2 study of bevacizumab with carboplatin–paclitaxel for non-small cell lung cancer with malignant pleural effusion
M Tamiya, A Tamiya, T Yamadori, K Nakao, K Asami… - Medical oncology, 2013 - Springer
Vascular endothelial growth factor (VEGF) is involved in non-small cell lung cancer
(NSCLC) with malignant pleural effusion (MPE), but little is known regarding the efficacy of …
(NSCLC) with malignant pleural effusion (MPE), but little is known regarding the efficacy of …
Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion
K Kitamura, K Kubota, M Ando, S Takahashi… - Cancer chemotherapy …, 2013 - Springer
Purpose The presence of malignant pleural effusion (MPE) indicates a poorer prognosis for
patients with non-small-cell lung cancer (NSCLC) and impairs their quality of life. Because …
patients with non-small-cell lung cancer (NSCLC) and impairs their quality of life. Because …
Immunogenic composition for immune system modulation and use thereof, method for treating and preventing diseases, method for inducing cell regeneration and …
AE Nowill - 2012 - Google Patents
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL
TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL …
TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL …
[HTML][HTML] Chemical pleurodesis for prolonged postoperative air leak in primary spontaneous pneumothorax
CH How, TM Tsai, SW Kuo, PM Huang, HH Hsu… - Journal of the Formosan …, 2014 - Elsevier
Background/Purpose Prolonged air leak is the most common complication after
thoracoscopic operation for primary spontaneous pneumothorax (PSP), and the role of …
thoracoscopic operation for primary spontaneous pneumothorax (PSP), and the role of …
Individualised management of malignant pleural effusion
AO Clive, R Bhatnagar, I Psallidas… - The Lancet Respiratory …, 2015 - thelancet.com
Comment 506 www. thelancet. com/respiratory Vol 3 July 2015 structures and improve
diagphragmatic motion, thereby enhancing respiratory mechanics and improving symptoms …
diagphragmatic motion, thereby enhancing respiratory mechanics and improving symptoms …